+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Exploitation of sperm-Escherichia coli interaction at the receptor-ligand level for the development of anti-receptor antibodies as the vaginal contraceptive



Exploitation of sperm-Escherichia coli interaction at the receptor-ligand level for the development of anti-receptor antibodies as the vaginal contraceptive



Andrology 3(2): 385-394



In an earlier work performed in our laboratory, we have been able to isolate a sperm receptor (SR) from human spermatozoa playing critical role in fertilization using sperm--E. coli interactions at the receptor-ligand level. It has been hypothesized that for the development of an immunocontraceptive, antibodies generated against the SR should have the ability to impair sperm parameters. In this league, an attempt was made to generate anti-SR antibodies and their effect on sperm parameters such as motility, viability, Mg(2+) -dependent ATPase activity, acrosome status, and apoptotic index was examined. Loss of sperm motility was observed with 100% agglutination. Interaction of anti-SR antibodies with spermatozoa resulted in reduced Mg(2+) -dependent ATPase activity (1020 ± 0.53%), premature acrosomal loss (61.5 ± 0.67%) as well as induced apoptosis (58.76 ± 2.5%). The induction of sperm damage was specifically because of anti-SR polyclonal antibodies as it could be mitigated by the addition of purified SR. Further, when in vivo efficacy of anti-SR antibodies was checked, results showed that a single intravaginal administration with anti-SR antibodies in female BALB/c mice led to the failure of conception. However, simultaneous administration of SR with anti-SR polyclonal antibodies resulted in sustenance of fertility. Infertility induced by anti-SR antibodies did not show any other tissue pathology; hence the present work highlights the potential of anti-SR polyclonal antibodies to be used as a vaginal contraceptive.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053136958

Download citation: RISBibTeXText

PMID: 25380035

DOI: 10.1111/andr.290


Related references

High level expression of full length EP3 receptor in Escherichia coli and production of antibodies to the purified receptor. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 413A, 1998

Development of polyclonal anti-D2 dopamine receptor antibodies to fusion proteins: Inhibition of D2 receptor-G protein interaction. Journal of Neurochemistry 60(6): 2181-2191, 1993

Escherichia coli recombinant sperm immobilizing factor RecX as a potential vaginal contraceptive. Reproductive Biology and Endocrinology 16(1): 88, 2018

Immunopharmacological aspects of ligand-receptor interaction: anti-idiotypic antibodies with pharmacological activity. Farmakologiia i Toksikologiia 50(4): 72-78, 1987

Receptor analogs and anti pili antibodies as inhibitors of attachment of uro pathogenic escherichia coli. Strober, W , L A Hanson And K W Sell (Ed ) Recent Advances in Mucosal Immunity Xviii+435p Raven Press: New York, N Y , Usa Illus P355-370, 1982

High level expression of a glucocorticoid receptor fragment in escherichia coli and its use in the generation of novel monoclonal antibodies. Journal of Cellular Biochemistry Suppl. (11 Part A): 106, 1987

Development of 7TM receptor-ligand complex models using ligand-biased, semi-empirical helix-bundle repacking in torsion space: application to the agonist interaction of the human dopamine D2 receptor. Journal of Computer-Aided Molecular Design 27(3): 277-291, 2013

Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein a-subunits. The Journal of Biological Chemistry 267: 00-6, 1992

Characterization of the binding of two anti crp monoclonal antibodies to the crp598 mutant of the escherichia coli cyclic amp receptor protein. FASEB Journal 4(7): A1984, 1990

Inhibition of Escherichia coli heat-labile enterotoxin by neoglycoprotein and anti-lectin antibodies which mimic GM1 receptor. FEMS Microbiology Letters 216(1): 67-70, 29 October, 2002

Characterization of anti-idiotypic antibodies recognizing the alpha interferon receptor Implications for ligand-receptor interactions. Journal of Interferon Research 12(Suppl. 1): S216, 1992

Role of insulin receptor dimerization domains in ligand binding, cooperativity, and modulation by anti-receptor antibodies. Journal of Biological Chemistry 277(19): 16718-16725, 2002

Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. Journal of Biological Chemistry 267(12): 8200-8206, 1992

Effects of co-expression of liver X receptor β-ligand binding domain with its partner, retinoid X receptor α-ligand binding domain, on their solubility and biological activity in Escherichia coli. Journal of Microbiology and Biotechnology 25(2): 247-254, 2015

Generation and characterization of anti-idiotypic antibodies recognizing the interferon-alpha receptor: implications for ligand-receptor interactions. Journal of Interferon Research 13(4): 295-301, 1993